Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications After Myocardial Infarction
1999 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
The management of acute myocardial infarction: guidelines and audit standards. Report of a workshop of the Joint Audit Committee of the British Cardiac Society and the Royal College of Physicians.
1994
Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.
1989
Potentially dangerous effect of disopyramide on atrioventricular conduction in a patient on digitalis.
1980
Should patients with acute coronary disease be stratified for management according to their risk? Derivation, external validation and outcomes using the updated GRACE risk score
2014
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Size isn't everything
2002
Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction
1993
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Diabetic Foot Ulcers and Their Recurrence
2017 Standout
Relationships Between Authors of Clinical Practice Guidelines and the Pharmaceutical Industry
2002 Standout
Diltiazem in acute myocardial infarction treated with thrombolytic agents: a randomised placebo-controlled trial
2000
The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor
1997 StandoutNobel
“Do GRACE (Global Registry of Acute Coronary events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes?”
2010
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
1997 Standout
Use of doping agents, particularly anabolic steroids, in sports and society
2008 Standout
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
1995 Standout
The Quality of Health Care Delivered to Adults in the United States
2003 Standout
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 Standout
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
2009 Standout
A Randomized, Controlled Trial of the Use of Pulmonary-Artery Catheters in High-Risk Surgical Patients
2003 Standout
Association of Changes in Clinical Characteristics and Management With Improvement in Survival Among Patients With ST-Elevation Myocardial Infarction
2012
Guidelines for the early management of patients with myocardial infarction
1994
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Moderate hypothermia in patients with severe head injury: cerebral and extracerebral effects
1996
Critical appraisal of recent studies on nifedipine and other calcium channel blockers in coronary artery disease and hypertension
1996
SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION
1988 Standout
Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain
1988
TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: A meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients
2012
A Comparison of Observational Studies and Randomized, Controlled Trials
2000 Standout
Impact of hospital thrombolysis policy on out-of-hospital response to suspected myocardial infarction
1993
Parenteral inotropic support for advancedcongestive heart failure
1998
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
2002 Standout
Impact of age on management and outcome of acute coronary syndrome: Observations from the global registry of acute coronary events (GRACE)
2005
Pharmacologic Management of Supraventricular Tachycardias in Children
1997
Brief Report: Chlamydia Psittaci Endocarditis Diagnosed by Blood Culture
1992
Myocardial Reperfusion Injury
2007 Standout
Risk scores in acute coronary syndrome and percutaneous coronary intervention: A review
2013
Adjunctive Drug Therapy of Acute Myocardial Infarction — Evidence from Clinical Trials
1996
Nifedipine in acute myocardial infarction: an assessment of left ventricular function, infarct size, and infarct expansion. A double blind, randomised, placebo controlled trial.
1988
Comparative class 1 electrophysiologic and anticholinergic effects of disopyramide and its main metabolite (mono-N-dealkylated disopyramide) in healthy humans
1992
Resolving inequalities in care? Reduced mortality in the elderly after acute coronary syndromes. The Myocardial Ischaemia National Audit Project 2003-2010
2011
Early management of unstable angina and non-ST-segment elevation myocardial infarction: summary of NICE guidance
2010
Conflict of Interest in the Debate over Calcium-Channel Antagonists
1998 Standout
Infective endocarditis
2004 Standout
Treatment of Traumatic Brain Injury with Moderate Hypothermia
1997 Standout
Exercise limitation in chronic heart failure: Central role of the periphery
1996
The Global Registry of Acute Coronary Events, 1999 to 2009–GRACE
2010
Prognosis of patients with unstable angina or acute myocardial infarction treated with calcium channel antagonists
1996
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
1988 Standout
Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome
2011
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
1987 Standout
Role of electrophysiologic testing in the diagnosis and treatment of patients with known and suspected bradycardias and tachycardias
1981
Association Between Palliative Care and Patient and Caregiver Outcomes
2016 Standout
The Risk of Myocardial Infarction Associated With Antihypertensive Drug Therapies
1995 Standout
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
TREATMENT OF HYPERLIPIDAEMIA RETARDS PROGRESSION OF SYMPTOMATIC FEMORAL ATHEROSCLEROSIS A Randomised Controlled Trial
1983
Embolic phenomena in chlamydial infection
1980
A Decade of Clinical Trial Developments in Postmyocardial Infarction, Congestive Heart Failure, and Sustained Ventricular Tachyarrhythmia Patients: From CAST to AVID and Beyond
1998
PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE
1975 Standout
Serological cross-reactions between Bartonella and Chlamydia species: implications for diagnosis
1997
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
The German and Belgian accreditation models for diabetic foot services
2015
Women, work and coronary heart disease: prospective findings from the Framingham heart study.
1980
Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide.
1982 StandoutNobel
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.
1975
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options
2010
A randomized controlled study of a home health care team.
1985
Choosing between randomised and non-randomised studies: a systematic review.
1998
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
A Randomized Clinical Trial of the Effect of Deliberate Perioperative Increase of Oxygen Delivery on Mortality in High-Risk Surgical Patients
1993
Sudden Cardiac Death
1998 Standout
Does Hospital Competition Save Lives? Evidence from the English NHS Patient Choice Reforms
2011 Standout
Blood pressure, stroke, and coronary heart disease
1990 Standout
Endocarditis as a manifestation of Chlamydia B infection (psittacosis).
1977
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Relationship of plasma HDL-Cholesterol to testosterone, estradiol, and sex-hormone-binding globulin levels in men and women
1983
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline
2012
Anticholinergic effects of disopyramide and quinidine on guinea pig myocardium. Mediation by direct muscarinic receptor blockade.
1980
Endocarditis associated with Chlamydia trachomatis infection.
1981
Endocarditis Due to Rare and Fastidious Bacteria
2001 Standout
Early administration of nifedipine in suspected acute myocardial infarction. The Secondary Prevention Reinfarction Israel Nifedipine Trial 2 Study.
1993
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Drugs Five Years Later: Disopyramide
1982
Part 14: Pediatric Advanced Life Support
2010 Standout
SERUM HIGH-DENSITY LIPOPROTEINS IN PERIPHERAL VASCULAR DISEASE
1978
Coronary heart disease — The global picture
1975
Assessment of long-term plasma exchange for familial hypercholesterolaemia.
1980
Human Aging: Usual and Successful
1987 StandoutScience
Nifedipine
1995 Standout
A Prospective Evaluation and Follow-up of Patients with Syncope
1983 Standout
Sex differences in the relationships between obesity, alcohol consumption and cigarette smoking and serum lipid and apolipoprotein concentrations in a normal population
1981
Insidious endocarditis caused by Chlamydia psittaci.
1975
Effect of nifedipine on enzymatically estimated infarct size in the early phase of acute myocardial infarction.
1988
Successful treatment by doxycycline of endocarditis caused by ornithosis.
1987
Efficacy of nifedipine and metoprolol in the early treatment of unstable angina in the coronary care unit: Findings from the Holland Interuniversity Nifedipine/metoprolol Trial (HINT)
1987
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011
Works of John Birkhead being referenced
A comparison of the effects of captopril and flosequinan in patients with severe heart failure
1992
Improving care for patients with acute coronary syndromes: initial results from the National Audit of Myocardial Infarction Project (MINAP)
2004
Determinants and outcomes of coronary angiography after non-ST-segment elevation myocardial infarction. A cohort study of the Myocardial Ischaemia National Audit Project (MINAP)
2009
Evaluation of risk scores for risk stratification of acute coronary syndromes in the Myocardial Infarction National Audit Project (MINAP) database
2008
Where are we today? Early results from MINAP, the national audit of myocardial infarction project
2003
Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004-5: observational study
2006
Early impact of insulin treatment on mortality for hyperglycaemic patients without known diabetes who present with an acute coronary syndrome
2007
Predictors of in-hospital mortality for patients admitted with ST-elevation myocardial infarction: a real-world study using the Myocardial Infarction National Audit Project (MINAP) database
2007
Time delays in provision of thrombolytic treatment in six district hospitals. Joint Audit Committee of the British Cardiac Society and a Cardiology Committee of Royal College of Physicians of London.
1992
FREQUENCY OF RISK FACTORS FOR ISCHÆMIC HEART-DISEASE IN A HEALTHY BRITISH POPULATION
1974
Endocarditis caused by a psittacosis agent.
1974
How the NHS cares for patients with heart attack. MINAP Tenth Public Report 2011. Myocardial Ischaemia National Audit Project.
2011
CLINICAL CARDIOVASCULAR PHARMACOLOGY OF DOBUTAMINE A SELECTIVE INOTROPIC CATECHOLAMINE
1974
Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods.
1977
Clinical electrophysiological effects of atenolol--a new cardioselective beta-blocking agent.
1978
Studies of intra-atrial conduction with bipolar atrial and His electrograms.
1973
Trial of early nifedipine in acute myocardial infarction: the Trent study.
1986